Publications by authors named "Houston Holmes"

Claim this Profile
P
Phase 2 study of add-on parsaclisib for patients with myelofibrosis and suboptimal response to ruxolitinib: final results.
Abdulraheem Yacoub, Uma Borate, Raajit K Rampal, Haris Ali, Eunice S Wang, Houston Holmes

Blood Adv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-Year Follow-Up of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma, Including High-Risk Subgroups, in the ZUMA-2 Study.
Michael Wang, Javier Munoz, Andre Goy, Frederick L Locke, Caron A Jacobson, Houston Holmes

J Clin Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia: ZUMA-3 phase 1 results.
Bijal D Shah, Michael R Bishop, Olalekan O Oluwole, Aaron C Logan, Maria R Baer, Houston Holmes

Blood· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma.
Michael Wang, Javier Munoz, Andre Goy, Frederick L Locke, Caron A Jacobson, Houston Holmes

N Engl J Med· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast implant-associated anaplastic large cell lymphoma.
Lindsay Keith, William Herlihy, Houston Holmes, Paul Pin

Proc (Bayl Univ Med Cent)· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Report of a phase II study of clofarabine and cytarabine in de novo and relapsed and refractory AML patients and in selected elderly patients at high risk for anthracycline toxicity.
Edward Agura, Barry Cooper, Houston Holmes, Estil Vance, Robert Brian Berryman

Oncologist· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD5-positive, cyclinD1-negative mantle cell lymphoma with a translocation involving the CCND2 gene and the IGL locus.
Shirley Michelle Shiller, Arthur Zieske, Houston Holmes, Andrew L Feldman, Mark E Law

Cancer Genet· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical strategies for supporting the untransfusable hemorrhaging patient.
Gavin M Melmed, Meredith E Hulsey, Mike Newhouse, Houston E Holmes, Edward J Mays

Proc (Bayl Univ Med Cent)· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Composite lymphocyte-rich Hodgkin lymphoma and peripheral T-cell lymphoma associated with Epstein-Barr virus: a case report and review of the literature.
Steven Sanchez, Houston Holmes, Nora Katabi, Joe Newman, Rana Domiatti-Saad

Arch Pathol Lab Med· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of recombinant human antithrombin in patients with congenital antithrombin deficiency undergoing surgical procedures.
Barbara A Konkle, Kenneth A Bauer, Robert Weinstein, Anne Greist, Houston E Holmes

Transfusion· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantation.
John E Levine, Thomas Braun, Samuel L Penza, Patrick Beatty, Kenneth Cornetta, Houston E Holmes

J Clin Oncol· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis